NCT06963021 · Interventional trial
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Overall registry status Recruiting
Phase 3
Conditions Major Depressive Disorder
Delaware Valley sites
- Neurocrine Clinical Site · Cherry Hill, NJ · Camden County · Recruiting
- Neurocrine Clinical Site · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory